Skylar is an associate editor for The American Journal of Managed Care® (AJMC®) and The Center for Biosimilars®, and joined AJMC® in 2020. She is responsible for covering all aspects of the ever-changing global biosimilar industry and produces content that is accessible and informative for all health care stakeholders.
She has a BA in journalism and media studies from Rutgers University. You can connect with Skylar on LinkedIn.
Study Offers Snapshot of Successes and Challenges of Teens and Young Adults With SMA
Results of a survey depicting the ways that spinal muscular atrophy (SMA) affects the lives of adolescents and young adults revealed areas of support that need to be addressed to ensure that patients are able to live their best possible lives.
Researchers Identify Patients With COPD at Risk for Hypercapnia Development
Researchers analyzed 2 cohorts of patients with chronic obstructive pulmonary disease (COPD) to characterize who is most at risk for developing hypercapnia and who could most benefit from at-home noninvasive inhalation therapy.
Virtual Pulmonary Rehabilitation Programs for COPD Must Continue to Address Patient Access
Telerehabilitation programs for chronic obstructive pulmonary disease (COPD) have to address uptake barriers surrounding inadequate funding and access issues for elderly patients in order to last in a post–COVID-19 world, according to researchers.
Patients With Lower SES or Uncontrolled Disease May Be More Likely to Stop Biologic Therapy
Although 90% of patients with severe asthma choose to continue using a biologic, patients with worse disease control at baseline or with lower socioeconomic status (SES) may be more likely to cease biologic use, according to a poster presented at the American Academy of Allergy, Asthma & Immunology 2021 Annual Meeting.
Certain COPD, Asthma Medications May Increase COVID-19 Hospitalization Risk
Study results show that patients with chronic obstructive pulmonary disease (COPD) and comorbid asthma may have a greater risk of hospitalization from COVID-19 if they use bronchodilators or steroids plus bronchodilators.
Study Identifies Thousands of Potential Diagnosis Errors Among Patients With COPD
Researchers found that thousands of patients with chronic obstructive pulmonary disease (COPD) did not follow the traditional trajectory associated with the disease, suggesting a possible incorrect diagnosis.
Permanent Disability Claims for RA May Rise in Years Following COVID-19 Crisis
From 1999 to 2015, permanent disability claims for patients with rheumatoid arthritis (RA) spiked during periods of economic recessions, suggesting that the COVID-19 pandemic may create a similar effect in the near future.
Hospitalizations, ED Visits for COPD and Asthma Increase Under Certain Weather Conditions
Changes in temperature and atmospheric pressure were found to be associated with higher rates of medical care utilization for patients with chronic obstructive pulmonary disease (COPD) and asthma.
Study Finds CV Risk Is Unknown for Many Patients With COPD
A recent study found that the proportion of patients in the Netherlands with chronic obstructive pulmonary disease (COPD) who are being assessed for cardiovascular (CV) risk does not align with Dutch guideline recommendations.
Sunlight Exposure Linked to Reduced Disease Severity in MS
Investigators observed that some patients had improvements in their multiple sclerosis (MS) severity with increased sun exposure, whereas photosensitive individuals and those taking certain medications did not see the same effects.
Inhaled Sugar Formulation May Reduce Ventilation Duration, Improve Lung Function in AECOPD
A pilot study among hospitalized patients on the use of an inhaled naturally occurring sugar showed several positive outcomes for those with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).